Cargando…
An evaluation tool for FKBP12-dependent and -independent mTOR inhibitors using a combination of FKBP-mTOR fusion protein, DSC and NMR
Mammalian target of rapamycin (mTOR), a large multidomain protein kinase, regulates cell growth and metabolism in response to environmental signals. The FKBP rapamycin-binding (FRB) domain of mTOR is a validated therapeutic target for the development of immunosuppressant and anticancer drugs but is...
Autores principales: | Sekiguchi, Mitsuhiro, Kobashigawa, Yoshihiro, Kawasaki, Masashi, Yokochi, Masashi, Kiso, Tetsuo, Suzumura, Ken-ichi, Mori, Keitaro, Teramura, Toshio, Inagaki, Fuyuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196870/ https://www.ncbi.nlm.nih.gov/pubmed/21900305 http://dx.doi.org/10.1093/protein/gzr045 |
Ejemplares similares
-
Molecular Docking studies of FKBP12-mTOR inhibitors using binding predictions
por: Nasr, Arash Boroumand, et al.
Publicado: (2015) -
Rapamycin recruits SIRT2 for FKBP12 deacetylation during mTOR activity modulation in innate immunity
por: Hu, Lin, et al.
Publicado: (2021) -
FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway
por: Meng, Wen, et al.
Publicado: (2020) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)